Cold Water Irrigation for Post-ERCP Pancreatitis Prevention
This study is looking at whether adding cold water rinsing to a standard treatment can help prevent pancreatitis (inflammation of the pancreas) after an ERCP procedure. An ERCP is a procedure that uses a scope and X-rays to diagnose and treat problems in the bile and pancreatic ducts. All participants will receive rectal indomethacin, a medicine given to reduce inflammation. Some will also receive cold water rinsing, while others will receive room-temperature water rinsing. The study aims to see if cold water helps lower the chance of developing pancreatitis after ERCP. You may be able to join if you are at least 20 years old, have a native papilla (the opening where bile and pancreatic ducts join), and are having an ERCP. The study plans to enroll 950 people and is currently unclear on its recruitment status.
- Study design
- This is a randomized controlled study where participants are randomly assigned to one of two groups. It is a triple-blind study, meaning you, your doctor, and the researchers won't know which treatment you are receiving.
- What's involved
- You will have an ERCP procedure and receive a rectal indomethacin suppository. During the ERCP, you will receive either cold water or room-temperature water rinsing.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main outcome of the study, the incidence of pancreatitis, will be measured at approximately 24-36 months after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP) Pancreatitis
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Reza Hejazi · PRINCIPAL_INVESTIGATOR · University of Kansas
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Incidence of Post-ERCP Pancreatitis (PEP) between the cold water and control groupsapproximately 24-36 months.
The incidence of post-ERCP pancreatitis (PEP) is defined according to established consensus criteria as new or worsened abdominal pain persisting for at least 24 hours after ERCP, accompanied by serum amylase or lipase levels ≥3 times the upper limit of normal at approximately 24 hours post-procedure, and necessitating hospital admission or prolongation of planned observation.